Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients

• Status: Withdrawn
• Trial end date: 2014-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

Our objective is to assess whether pre-treatment with a fixed dose of insulin, based on weight, given to pregnant patients with gestational or preexisting diabetes receiving betamethasone can provide adequate glycemic control.

Our hypothesis is that pre-treatment with a weight-based calculated insulin dose will help maintain euglycemia for pregnant patients with gestational and preexisting diabetes after steroid administration, and possibly impact length of hospital admission.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Minnesota; University of Minnesota - Clinical and Translational Science Institute
• Treatments: Insulin; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

1. Pregnant women with gestational or pre-existing diabetes admitted to the University of Minnesota

2. Must be 18 years or older

3. Must speak English, Spanish, or Somali

4. Patients must receive steroids for fetal lung maturity as part of their hospital course

Exclusion Criteria:

1. Pregnant women with Type 1 Diabetes, or Type 2 diabetes with evidence of end-organ disease

2. Pregnant women who need to be emergently delivered due to maternal or fetal complications of pregnancy